Accrete Healthcare Profile
Key Indicators
- Authorised Capital ₹ 3.50 Cr
as on 27-12-2024
- Paid Up Capital ₹ 3.50 Cr
as on 27-12-2024
- Company Age 18 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 19.48 Cr
as on 27-12-2024
- Revenue 41.99%
(FY 2021)
- Profit 127.57%
(FY 2021)
- Ebitda 9.42%
(FY 2021)
- Net Worth 59.15%
(FY 2021)
- Total Assets -7.23%
(FY 2021)
About Accrete Healthcare
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.50 Cr and a paid-up capital of Rs 3.50 Cr.
The company currently has active open charges totaling ₹19.48 Cr.
Manzoor Wagay, Mohammad Wagay, Afroza Akhtar, and Three other members serve as directors at the Company.
- CIN/LLPIN
U85110JK2006PTC002702
- Company No.
002702
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Sep 2006
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Jammu
Industry
Company Details
- Location
Srinagar, Jammu & Kashmir, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Accrete Healthcare?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manzoor Wagay  | Director | 18-Sep-2006 | Current |
| Mohammad Wagay | Director | 18-Sep-2006 | Current |
| Afroza Akhtar | Director | 05-Oct-2012 | Current |
| Bilqees Ara | Director | 05-Oct-2012 | Current |
| Nundi Begum | Director | 05-Oct-2012 | Current |
| Ulfat Ara | Director | 05-Oct-2012 | Current |
Financial Performance of Accrete Healthcare.
Accrete Healthcare Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 41.99% increase. The company also saw a substantial improvement in profitability, with a 127.57% increase in profit. The company's net worth Soared by an impressive increase of 59.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Accrete Healthcare?
In 2020, Accrete Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Shikshak Sahakari Bank Limited Creation Date: 09 Oct 2024 | ₹1.54 M | Open |
The Jammu And Kashmir Bank Limited Creation Date: 03 Oct 2024 | ₹2.40 M | Open |
The Jammu And Kashmir Bank Limited Creation Date: 03 Oct 2024 | ₹2.00 M | Open |
How Many Employees Work at Accrete Healthcare?
Unlock and access historical data on people associated with Accrete Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Accrete Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Accrete Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
